A Therapeutic Trial of Human Amniotic Epithelial Cells Transplantation for Primary Ovarian Failure (POF)
Sponsor: International Peace Maternity and Child Health Hospital
A PHASE1 clinical study on Infertility and Premature Ovarian Failure, this trial is completed. The trial is conducted by International Peace Maternity and Child Health Hospital and has accumulated 11 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Apr 2023 — Jul 2024 [monthly]
Completed PHASE1
Status: Recruiting → Completed
-
Feb 2022 — Apr 2023 [monthly]
Recruiting PHASE1
-
Jan 2022 — Feb 2022 [monthly]
Recruiting PHASE1
▶ Show 6 earlier versions
-
Sep 2021 — Jan 2022 [monthly]
Recruiting PHASE1
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE1
-
Sep 2020 — Jan 2021 [monthly]
Recruiting PHASE1
Status: Unknown Status → Recruiting
-
Oct 2018 — Sep 2020 [monthly]
Unknown Status PHASE1
Status: Recruiting → Unknown Status
-
Jun 2018 — Oct 2018 [monthly]
Recruiting PHASE1
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- International Peace Maternity and Child Health Hospital
- Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China
For direct contact, visit the study record on ClinicalTrials.gov .